GP Prima 100

GP Prima 100 – Methenolone Enanthate Overview

GP Prima 100 is an injectable anabolic steroid from Geneza Pharmaceuticals containing Methenolone Enanthate at 100 mg/ml in a 10 ml vial. Methenolone Enanthate is the long-ester injectable form of Methenolone, marketed under the brand name Primobolan Depot. The Enanthate ester produces a half-life of approximately 7-10 days, making once or twice-weekly injections the most consistently referenced schedule. Commonly searched as Primo, Primobolan, Primobolan Depot, Primo E, and Geneza Primo.

What Is Methenolone Enanthate?

Methenolone Enanthate is a DHT-derived anabolic steroid – structurally related to dihydrotestosterone but with modifications that produce a mild androgenic profile and no aromatization to estrogen. The absence of aromatization is one of the most consistently cited pharmacological properties of Primobolan: estrogen-related side effects such as water retention and gynecomastia are not attributed to Primobolan itself. The Enanthate ester gives the injectable form (Primobolan Depot) a long release profile with a half-life of approximately 7-10 days. HPTA suppression is present with Methenolone Enanthate – a testosterone base is referenced as the standard companion for Primo cycles to maintain androgen levels while the HPTA is suppressed.

Why Users Search for GP Prima 100

Primobolan is among the most consistently searched compounds in cutting, lean mass, and body recomposition frameworks. Its reputation centers on a favorable side effect profile compared to other anabolic steroids: no aromatization, lower androgenic activity than testosterone, and mild impact on lipid markers relative to orals and more androgenic injectables. Primobolan vs Anavar is one of the most frequently compared compound pairs in community discussions. Primobolan vs Masteron is another common search angle – both are DHT-derived non-aromatizing cutting compounds, differentiated primarily by androgenic activity, oil release profile, and use context. Test + Primo is the most cited foundational Primobolan stack in community references.

• Active substance: Methenolone Enanthate – DHT-derived injectable, Enanthate ester, non-aromatizing, half-life approximately 7-10 days.
• Concentration: 100 mg/ml in a 10 ml vial – 1000 mg Methenolone Enanthate total content.
• Injection schedule: Once or twice-weekly cited for blood level stability with the Enanthate ester.
• Common names: Primo, Primobolan, Primobolan Depot, Primo E, Primo Enanthate, Methenolone E, Geneza Primo.
• Cycle context: Test + Primo stack; cutting, lean mass, and body recomposition frameworks; non-aromatizing DHT-derived alternative to Masteron.

GP Prima 100 Dose and Concentration Information

GP Prima 100 is listed at 100 mg/ml. A 10 ml vial contains 1000 mg Methenolone Enanthate in total. The Enanthate ester produces a half-life of approximately 7-10 days, making once or twice-weekly injections the most consistently referenced schedule for stable blood levels. This injection frequency is comparable to other long-ester injectables such as Testosterone Enanthate and Nandrolone Decanoate, and more convenient than shorter-ester alternatives.

Concentration and Ester Context

100 mg/ml is the standard concentration for injectable Methenolone Enanthate (Primobolan Depot). The Enanthate ester’s half-life of approximately 7-10 days allows stable blood levels with once or twice-weekly injections and PCT timing beginning approximately 14 days after the last injection – the same window cited for other Enanthate-ester compounds such as Testosterone Enanthate and Trenbolone Enanthate. Methenolone Enanthate does not aromatize to estrogen – estrogen monitoring in a GP Prima 100 cycle is required for the testosterone base used alongside it, not for Primo itself.

Bloodwork and Monitoring Context

Methenolone Enanthate does not aromatize and has a lower androgenic rating than testosterone, which is reflected in a commonly cited milder bloodwork impact profile compared to more androgenic or aromatizing compounds. Lipid panel monitoring is referenced – Primobolan’s impact on HDL/LDL is generally cited as milder than 17-alpha alkylated orals or Trenbolone, but is still a monitored variable for any anabolic cycle. Hematocrit, blood pressure, and liver enzymes are standard injectable cycle monitoring references. HPTA suppression is present – a mandatory testosterone base is the consistent community reference for all Primo cycles.

• Concentration: 100 mg/ml – standard Methenolone Enanthate injectable concentration.
• Total content: 1000 mg Methenolone Enanthate per 10 ml vial.
• Injection schedule: Once or twice-weekly cited for stable blood levels with the Enanthate ester.
• PCT timing: Approximately 14 days post-last-injection – consistent with other Enanthate-ester compounds.
• Estrogen context: Primo does not aromatize – estrogen monitoring applies to the testosterone base, not Methenolone itself.
• Bloodwork context: Lipid panel, hematocrit, blood pressure – standard monitoring for long-ester injectable cycles.
• Testosterone base: Universally cited as mandatory alongside all Primo cycles – HPTA suppression is complete.